Gilead Sciences, Inc. (GILD)
118.84
-4.56
(-3.70%)
USD |
NASDAQ |
Nov 07, 16:00
118.95
+0.11
(+0.09%)
After-Hours: 20:00
Gilead Sciences Total Assets (Quarterly): 58.53B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.14B |
| Eli Lilly & Co. | 114.94B |
| Merck & Co., Inc. | 129.55B |
| Pfizer Inc. | 208.73B |
| Bristol Myers Squibb Co. | 96.89B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.08B |
| Shareholders Equity (Quarterly) | 21.46B |
| Current Ratio | 1.532 |
| Net Debt Paydown Yield | 3.39% |